Company Data
IN8bio Inc.
Ticker
INAB
Current Price
$1.74 -2.25%
Market Cap
$8.1M
Price Target
Refer to Report
Volume
16.7K
52wk Range
$1.5301 - $12.531
Overview
IN8bio Inc is a clinical-stage biotechnology company. It is focused on developing innovative therapies for the treatment of cancers, including solid tumors, by employing allogeneic, autologous and genetically modified gamma-delta T cells.